NCT06677008

Brief Summary

This study conducted a Post-Market Clinical Follow-Up study (PMCF) to evaluate the safety and effectiveness of the disposable endoscopic linear cutter stapler produced by Changzhou Ankang Medical Instrument Co., Ltd., through a retrospective analysis of the clinical data, to evaluate the safety and effectiveness of soft tissue resection, transection and anastomosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
302

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 4, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 6, 2024

Completed
9 days until next milestone

Study Start

First participant enrolled

November 15, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2025

Completed
Last Updated

November 6, 2024

Status Verified

November 1, 2024

Enrollment Period

4 months

First QC Date

November 4, 2024

Last Update Submit

November 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Anastomosis success rate

    The condition of no reoperation in situ was defined as successful anastomosis as determined by surgical records and hospitalization medical records.

    the investigation sites will be collected from January 2023 to September 2024.

Secondary Outcomes (5)

  • Operation time

    The investigation sites will be collected from January 2023 to September 2024.

  • Amount of intraoperative blood loss

    the investigation sites will be collected from January 2023 to September 2024.

  • Intraoperative conversion (caused by the stapler and/or cartridge)

    the investigation sites will be collected from January 2023 to September 2024.

  • Length of hospitalization

    the investigation sites will be collected from January 2023 to September 2024.

  • All-cause re-hospitalization rate (within 6 months)

    From the date of surgery to six months after the surgery

Other Outcomes (3)

  • Adverse events

    From the date of surgery to six months after the surgery

  • Device deficiencies

    From the date of surgery to six months after the surgery

  • Serious adverse events

    From the date of surgery to six months after the surgery

Study Arms (1)

Disposable endoscopic linear cutter stapler

Device: Disposable endoscopic linear cutter stapler

Interventions

Investigational devices of all the models of the staplers and its cartridge listed in Study Plan(Plan number: CAK-PMCF)

Disposable endoscopic linear cutter stapler

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

For patients who need to be operated for abdominal, gynecologic, pediatric, and thoracic, endoscopic (i.e., endo-therapy) surgery for the expeditious transection/resection of tissues and creation of anastomoses.

You may qualify if:

  • Age unlimited and gender unlimited;
  • The surgery type shall be endoscopic surgery;
  • The departments of surgical procedures: general and thoracic surgical procedures;
  • Investigational devices of all the models of the staplers and its cartridge listed in Section 2.3.

You may not qualify if:

  • Patients undergoing surgery for contraindications to the product, such as severe mucosal edema, non-observation of hemostatic sites for surgery or off-label use, such as liver and spleen;
  • Combined with other similar products (stapler) for resection, transection and anastomosis of the surgical site;
  • Surgery record is incomplete, unable to extract main indicators related information.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Disposable endoscopic linear cutter stapler

Wujin District, Changzhou, China

Location

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 4, 2024

First Posted

November 6, 2024

Study Start

November 15, 2024

Primary Completion

February 28, 2025

Study Completion

February 28, 2025

Last Updated

November 6, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations